Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-28

Clinical Trial Update: Immunogenicity and Safety of a Purified Vero Rabies Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial update on immunogenicity and safety of a purified Vero Rabies vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified Vero Rabies Vaccine (Purified vero cell rabies vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Rabies Virus | Phase 2 | Status: COMPLETED | Results posted: 2021-01-28